AU2002368531A1 - Isolation of dihydropyridine derivative and preparation salts thereof - Google Patents

Isolation of dihydropyridine derivative and preparation salts thereof

Info

Publication number
AU2002368531A1
AU2002368531A1 AU2002368531A AU2002368531A AU2002368531A1 AU 2002368531 A1 AU2002368531 A1 AU 2002368531A1 AU 2002368531 A AU2002368531 A AU 2002368531A AU 2002368531 A AU2002368531 A AU 2002368531A AU 2002368531 A1 AU2002368531 A1 AU 2002368531A1
Authority
AU
Australia
Prior art keywords
isolation
dihydropyridine derivative
preparation salts
salts
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368531A
Inventor
Mustafa Adiyaman
Tuncer Aslan
Didem Guner
Evren A. Ozarslan
Nurten Ridvanoglu
Filiz Sahpaz
Aycil Yurdakul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva Kinyasal Urunleri Sanayi ve Ticaret AS
Original Assignee
EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi ve Ticaret AS filed Critical EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi ve Ticaret AS
Publication of AU2002368531A1 publication Critical patent/AU2002368531A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
AU2002368531A 2002-12-30 2002-12-30 Isolation of dihydropyridine derivative and preparation salts thereof Abandoned AU2002368531A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2002/000078 WO2004058711A1 (en) 2002-12-30 2002-12-30 Isolation of dihydropyridine derivative and preparation salts thereof

Publications (1)

Publication Number Publication Date
AU2002368531A1 true AU2002368531A1 (en) 2004-07-22

Family

ID=32679808

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368531A Abandoned AU2002368531A1 (en) 2002-12-30 2002-12-30 Isolation of dihydropyridine derivative and preparation salts thereof

Country Status (2)

Country Link
AU (1) AU2002368531A1 (en)
WO (1) WO2004058711A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006224161A1 (en) 2005-03-15 2006-09-21 Lupin Limited Pharmaceutical compositions of amlodipine and benazepril
ES2265781B1 (en) * 2005-08-04 2007-12-01 Ercros Industrial, S.A. PROCEDURE FOR OBTAINING AMLODIPINE BESYLATE.
EP1975167A1 (en) 2007-03-30 2008-10-01 Esteve Quimica, S.A. Acetone solvate of phthaloyl amlodipine
CN102070516A (en) * 2011-02-22 2011-05-25 广东东阳光药业有限公司 Method for preparing amlodipine
JP5952748B2 (en) * 2013-01-25 2016-07-13 東和薬品株式会社 Novel crystalline form of phthaloyl amlodipine and process for producing high purity amlodipine besylate using the same
CN104262237A (en) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 Synthesis method of amlodipine free alkali
CN112538044B (en) * 2019-12-09 2021-08-13 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, and preparation method and application thereof
CN111103368B (en) * 2019-12-23 2022-06-28 河北科技大学 Method for predicting validity period of esomeprazole enteric-coated tablet
GB202102575D0 (en) 2021-02-23 2021-04-07 Teva Pharmaceutical Industries Ltd Fixed-dose pharmaceutical compositions
CN117723679B (en) * 2024-02-05 2024-05-24 长沙创新药物工业技术研究院有限公司 Detection method of R-/S-hydroxypropyl tetrahydropyran triol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (en) * 1982-03-11 1991-12-09 Pfizer CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (en) * 1992-11-26 1998-06-30 Lek, New process for preparing benzensulfonate salts
CH692199A8 (en) * 1997-10-09 2002-06-14 Cermol S.A. PYRIDIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
BR0116557A (en) * 2000-12-29 2003-10-28 Pfizer Ltd Process, process for making a substantially amlodipine aspartate free amlodipine maleate salt, process for purification, amlodipine maleate, pharmaceutical composition for treating or preventing angina or hypertension, method for treating hypertension, angina or heart attack, benzene sulfonate amlodipine, amlodipine hydrochloride and use of amlodipine substantially free of amlodipine aspartate maleate
CA2433181C (en) * 2000-12-29 2005-11-22 Pfizer Limited Amlodipine hemifumarate
GB0120808D0 (en) * 2001-08-28 2001-10-17 Pfizer Ltd Crystalline material
DE20201878U1 (en) * 2002-02-07 2002-07-11 Bioorganics B.V., Nijmegen Free amlodipine base

Also Published As

Publication number Publication date
WO2004058711A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2002363005A1 (en) Derivatives of uk-2a
AU2001263021A1 (en) Alkylamine derivatives of dihydropyridine npy antagonists
AU2003255982A1 (en) Preparation of microcapsules
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2002338695A1 (en) Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives
IL175657A0 (en) Derivatives of dihydronepetalactone and method for preparation
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2003211047A1 (en) Method of preparation of 21-amino epothilone derivatives
AU2003277876A1 (en) Modified release formulations of oxcarbazepine and derivatives thereof
AU2002368531A1 (en) Isolation of dihydropyridine derivative and preparation salts thereof
IL161348A (en) Substituted 4- phenyl-4-[1h - imidazol-2-yl] piperidine derivatives and their use for the preparation of pharmaceutical compositions
AU2003234545A1 (en) Pharmaceutical compositions and methods of using c-21 modified epothilone derivatives
AU2002351388A1 (en) Methods and compositions for controlled release of drugs
AU2003224781A1 (en) Crystalline forms of rabeprazole sodium
AU2003252314A1 (en) 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003206872A1 (en) Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
AU2003230320A1 (en) Sustained release formulation of protein and preparation method thereof
AU2002364911A1 (en) Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
AU2002351056A1 (en) Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2002304338A1 (en) Highly purified and crystalline form of harringtonine
AU2003215947A1 (en) Controlled release composition comprising felodipine and method of preparation thereof
AU2003298725A1 (en) Preparation of metallotexaphyrins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase